{
  "docId": "019de075-242a-7291-8f16-5f142d7cb798",
  "docSlug": "c8e6c54234adac3c3fb2311a09419808",
  "documentTitle": "Freeman Capital Management | Activist Presentation Deck | 15 slides",
  "authorId": "freeman-capital-management",
  "authorName": "Freeman Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 13,
  "pageCount": 15,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": "The slide uses a list of 'x' marks to emphasize omissions.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-242a-7291-8f16-5f142d7cb798/13",
  "deckHref": "/decks/019de075-242a-7291-8f16-5f142d7cb798",
  "deckJsonHref": "/decks/019de075-242a-7291-8f16-5f142d7cb798.json",
  "deckAnchorHref": "/decks/019de075-242a-7291-8f16-5f142d7cb798#slide-13",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.44,
        "x": 0.28,
        "y": 0.79
      },
      "kind": "callout",
      "text": "There are no shareholder voices in the boardroom who are willing or capable to hold management to account.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "764380b2-1a92-4f50-ab05-a96d5bb32f5c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.55,
        "x": 0.23,
        "y": 0.25
      },
      "kind": "list",
      "text": "The Board has entrenched management with golden parachutes.\nThe Board approved the MM-110 dosing without proper safety data, and the flawed, unnecessary Phase IIb.\nThe Board's lack of alignment with shareholders owning just .22% of outstanding MindMed shares v. FCM's 3.5% beneficial ownership.\nOur pledge to lock up our shares until June 15, 2026, demonstrating alignment with shareholders.\nThe numerous unfulfilled promises that MindMed has made including purported partnerships in digital medicine and Phase II trials.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3ba8c48-ec6e-4b24-9b59-30f790cdcb95",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.15,
        "x": 0.05,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Company SEC Filings",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1dc2ae5f-9361-4d86-a58b-882a52d053a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "What ISS Left Completely Out",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61675d57-0714-499a-89fe-f85503cc0e1f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "99323545-9a7f-4c99-8e59-912c33ba76c8",
      "evidence": "The slide explicitly lists failures and omissions by the board to build a case for mismanagement.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 13,
      "beatId": "64d1132b-b638-45d0-85c8-3bf96678b675",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Struggle (Freeman Capital Management's efforts)",
      "beatSlug": "overcoming-monster-the-struggle",
      "evidence": "Slides 13-14 present Dr. Freeman's actions and the conclusion.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 13,
      "name": "The Reveal",
      "slug": "05-the-reveal",
      "bestFor": "Product launches, strategic pivots, unexpected findings",
      "matchId": "d42f7ac4-dd89-40b9-860d-e7cfdbbe2b7b",
      "evidence": "Slides 13-15 present Dr. Freeman's actions and the conclusion.",
      "position": 0,
      "objective": "Reveal Freeman Capital Management's solution and call to action",
      "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
      "confidence": 0.7,
      "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}